Hercbergs, Aleck
Mousa, Shaker A.
Leinung, Matthew
Lin, Hung-Yun
Davis, Paul J.
Article History
Received: 4 January 2018
Accepted: 29 January 2018
First Online: 13 February 2018
Compliance with Ethical Standards
:
: Co-authors Davis and Mousa are stockholders in NanoPharmaceuticals LLC that is commercially developing tetrac analogues, and Davis is an officer of the company. All remaining authors have no conflicts to declare.